William Blair & Company’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-7,506
| Closed | -$73K | – | 1450 |
|
|
2017
Q2 | $73K | Sell |
7,506
-30,510
| -80% | -$297K | ﹤0.01% | 1380 |
|
|
2017
Q1 | $918K | Sell |
38,016
-953
| -2% | -$23K | 0.01% | 726 |
|
|
2016
Q4 | $1.25M | Sell |
38,969
-318
| -0.8% | -$10.2K | 0.01% | 603 |
|
|
2016
Q3 | $1.96M | Buy |
39,287
+2,828
| +8% | +$141K | 0.02% | 498 |
|
|
2016
Q2 | $1.55M | Sell |
36,459
-2,224
| -6% | -$94.3K | 0.01% | 519 |
|
|
2016
Q1 | $2.55M | Sell |
38,683
-349
| -0.9% | -$23K | 0.02% | 402 |
|
|
2015
Q4 | $2.43M | Sell |
39,032
-509
| -1% | -$31.6K | 0.02% | 421 |
|
|
2015
Q3 | $2.65M | Sell |
39,541
-6,450
| -14% | -$432K | 0.02% | 458 |
|
|
2015
Q2 | $4.47M | Buy |
45,991
+2,078
| +5% | +$202K | 0.01% | 1104 |
|
|
2015
Q1 | $4.1M | Sell |
43,913
-4,989
| -10% | -$466K | 0.01% | 1093 |
|
|
2014
Q4 | $4.35M | Sell |
48,902
-4,950
| -9% | -$440K | 0.01% | 1074 |
|
|
2014
Q3 | $3.72M | Buy |
53,852
+178
| +0.3% | +$12.3K | 0.01% | 1086 |
|
|
2014
Q2 | $3.08M | Buy |
53,674
+5,430
| +11% | +$311K | 0.01% | 1121 |
|
|
2014
Q1 | $1.91M | Buy |
48,244
+12,897
| +36% | +$511K | ﹤0.01% | 1217 |
|
|
2013
Q4 | $1.49M | Buy |
+35,347
| New | +$1.49M | ﹤0.01% | 1267 |
|